Lisdexamfetamine Dimesylate Capsule
Product Images NDC 65162-024

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lisdexamfetamine Dimesylate (NDC 65162-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8c301747-figure-01 (Lisdexamfetamine Dimesylate Capsules 1)

FDA Label Image

20 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 10)

FDA Label Image

30 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 11)

30 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 11)
This is a description of a medication in capsule form. Each capsule contains 30mg of Lisdexamfetamine dimesylate. The dosage information can be found in the package insert. The capsules should be stored between 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F) as per USP Controlled Room Temperature guidelines. The medication should be dispensed in a tight, light-resistant container. It is manufactured by Amneal Pharmaceuticals of NY, LLC and distributed by Amneal Pharmaceuticals LLC in Glasgow, KY. The revision date is March 2021.*
FDA Label Image

20 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 12)

FDA Label Image

50 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 13)

FDA Label Image

60 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 14)

60 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 14)
Each capsule of this medication contains 60mg of lisdexamfetamine dimesylate. The package insert should be consulted for dosage information. The capsules should be stored at a temperature of 20 to 25°C (68°F to 77°F), with excursions between 15 to 30°C (59°F to 86°F) allowed. They should be dispensed in a tight, light-resistant container as per USP guidelines. This medication is manufactured by Amneal Pharmaceuticals of NY, LLC. Pharmacists should provide the Medication Guide separately to each patient. Distributed by Amneal Pharmaceuticals, LLC, located in Hauppauge, NY 1768. Revision date: 03-2021-00.*
FDA Label Image

70 mg 90 Ct Label (Lisdexamfetamine Dimesylate Capsules 15)

FDA Label Image

Figure 1 (Lisdexamfetamine Dimesylate Capsules 2)

FDA Label Image

2 (Lisdexamfetamine Dimesylate Capsules 3)

FDA Label Image

3 (Lisdexamfetamine Dimesylate Capsules 4)

FDA Label Image

1 (Lisdexamfetamine Dimesylate Capsules 5)

FDA Label Image

Figure 5 (Lisdexamfetamine Dimesylate Capsules 6)

FDA Label Image

6 (Lisdexamfetamine Dimesylate Capsules 7)

FDA Label Image

7 (Lisdexamfetamine Dimesylate Capsules 8)

FDA Label Image

Figure 8 (Lisdexamfetamine Dimesylate Capsules 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.